EuroEyes International Eye Clinic (HKSE:01846) FFO

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

HKSE:01846 EuroEyes International Eye Clinic Ltd HKSE:01846
79 GF Score
Price HK$2.48
GF Value HK$5.54
Valuation Significantly Undervalued
! 5 Warning Signs
View Full Analysis

What is EuroEyes International Eye Clinic FFO?

FFO (Funds from operations) only applies to REITs.

HKSE:01846
79GF Score
EuroEyes International Eye Clinic Ltd HKSE:01846
FFO is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is EuroEyes International Eye Clinic (HKSE:01846) Overvalued in 2026?

Based on GuruFocus' analysis, EuroEyes International Eye Clinic stock appears to be undervalued. The current stock price of HK$2.48 is trading 55.2% below its estimated GF Value™ of HK$5.54. GuruFocus considers EuroEyes International Eye Clinic to be Significantly Undervalued.

Key valuation signals for HKSE:01846:

  • FFO:
  • GF Value™: HK$5.54 vs. price of HK$2.48 (55.2% below fair value)
  • GF Score™: 79/100 with 5 warning signs

No single metric tells the full story. See the HKSE:01846 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

EuroEyes International Eye Clinic Business Description

Address Valentinskamp 90, Hamburg, DEU, 20355
EuroEyes International Eye Clinic Ltd is principally engaged in the provision of vision correction services in Germany, Denmark, the UK, the PRC including Hong Kong, and Switzerland. The Group is a high-end vision correction service provider in Germany, PRC, the UK, Denmark, and Switzerland. Its vision correction services include refractive laser surgery, phakic lens surgery (ICL), lens exchange surgery, and others including PRK/LASEK and ICRS implantation. Its revenue categories include provision of vision correction services generate maximum revenue, training services, sales of pharmaceutical products and others. The Group's five reportable segments are Germany generate maximum revenue, Denmark, UK, Chinese Mainland, and Switzerland.
79GF Score

Get the complete analysis for HKSE:01846

FFO is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

HK$2.48
Price
HK$5.54
GF Value